Data / Form D filings / SUNDANCE DIAGNOSTICS, INC.
SUNDANCE DIAGNOSTICS, INC.: Form D filings
SUNDANCE DIAGNOSTICS, INC., a biotechnology company in Boulder, CO, filed 5 Form D notices with the SEC between 2013 and 2015. The latest, on May 19, 2015, reports $5,513 sold of a $6,600 offering to 56 investors.
Find out what SUNDANCE DIAGNOSTICS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2525 ARAPAHOE AVENUE, SUITE E4-553, Boulder, CO, 80302
- Phone
- (303) 862-2770
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1568961
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2015 | New notice | $6,600 | $5,513 | $1,087 | 56 | Dec 30, 2011 | sec.gov |
| Oct 29, 2014 | Amendment | $1,553 | $1,553 | $0 | 7 | Dec 30, 2011 | sec.gov |
| Oct 28, 2014 | Amendment | $5,500 | $2,939 | $2,561 | 41 | Dec 30, 2011 | sec.gov |
| Mar 4, 2013 | Amendment | $1,100 | $1,000 | $100 | 13 | Dec 30, 2011 | sec.gov |
| Mar 1, 2013 | New notice | $1,100 | $1,000 | $100 | 13 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kim Bechthold | Executive Officer, Director | |
| Allan Ogilvie | Director | |
| Wayne H Bechthold | Executive Officer |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of May 18, 2015 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SUNDANCE DIAGNOSTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.